The Department of Justice has filed a complaint against a Houston-based company for falsely inflating pharmaceutical ingredient prices to over 400 times the actual cost for the purposes of defrauding TRICARE, a federal health care program. According to a press release on Nov. 8, the DOJ filed the complaint under the False Claims Act against…